Lori Englebert

Lori Englebert, Chief Commercial Officer of Compass Pathways, has spent her career seeking new challenges to achieve things others might say could never be done. Across more than fifteen product launches, Lori has built a reputation for entering underserved spaces with a combination of strategic acumen and creative thinking that empowers teams to answer some of the toughest questions that have kept patients waiting. At Compass, Lori’s unique approach to commercial leadership has shaped the infrastructure and the team for optimizing market conditions in support of the broadest possible access to Compass’ psychedelic treatment for people living with serious mental health conditions. In her view, commercial success and human impact are one and the same. With a commercial career spanning from large pharmaceutical companies to lean biotechs, including Axsome and Amgen, Lori understands the full arc of what it takes to move a breakthrough from clinical evidence to a patient’s hands, and every barrier that stands in between. She holds a B.A. and an MBA from Wake Forest University.  Lori joined Compass because she sees this work as once-in-a-generation: not just a first-in-class treatment, but a first-in-class opportunity to reimagine how mental healthcare reaches the people who need it most. More than a defining characteristic of the organization, Lori finds the culture of genuine collaboration as foundational to the company’s continued evolution and future success. She believes the first step to unlocking new pathways in mental healthcare begins with assembling that fundamentally united team, and then together finding the direction of where we want to go and how we’ll get there. Lori is not a traditional commercial leader and has never wanted to be. At Compass, taking the untraditional path is more than encouraged; it’s celebrated.